Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.51

+4.6%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (882)	10/9/1998 12:54:00 AM
From: Anthony Wong	Read Replies (1) of 1722

[BMY] US investor picks stocks that defy market fall-BSW Thursday October 8, 7:38 pm Eastern Time NEW YORK, Oct 8 (Reuters) - Tobacco giant Philip Morris Cos. Inc. (NYSE:MO - news), drugmaker Bristol-Myers Squibb Co. (NYSE:BMY - news) and telecom company Bell Atlantic Corp. (NYSE:BEL - news) are stocks that will buck the general stockmarket decline, according to a U.S. investment manager quoted in the the Oct. 19 edition of Business Week. Rob Lyon, president and chief investment officer at Institutional Capital in Chicago, told Business Week he sees Philip Morris heading for 65 over the next 12 months. The company's stock closed at 47-15/16 Thursday, down 15/16. ''Morris has been winning court battles,'' Lyon said. Bristol Myers, which closed at 92-1/4 Thursday, is an undervalued drugmaker with a large product pipeline that investors have yet to recognize, Lyons told the magazine. Lyon's target for the stock is 130. Lyon said Bell Atlantic has been bucking the market, rising through some dips, and he believes the stock is worth 65. Bell Atlantic closed at 51-5/8 Thursday, up 5/8.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next